Galmed Pharmaceuticals Ltd. (GLMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.23M |
| Enterprise Value | -751,510 |
| P/E Ratio | -0.27 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.25 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.69 |
| Return On Equity | -0.64 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -10.31M |
| Net Income | -10.31M |
| Diluted EPS | -19.12 |
| Total Cash | 15.45M |
| Total Cash/Share | 18.75 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.71 |
| Book Value Per Share | 16.93 |
| 52-Week Change | -61.84 |
| 52-Week High | 13.2 |
| 52-Week Low | 3.29 |
| Moving Average 50 Days | 4.52 |
| Moving Average 200 Days | 5.62 |
| Average Volume | 102,199 |
| Shares Outstanding | 1.03M |
| % Held by Institutions | 4.98 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | August 19, 2026 |